Novel anti-ST2 monoclonal antibody astegolimab modestly reduced chronic obstructive pulmonary disease (COPD) exacerbations in ...

Dr. Rojas-Quintero is researching how Metformin, a long-used diabetes drug, may be able to slow fibrosis in the lungs.

Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...

A new Northwestern Medicine study is challenging long-held assumptions about chronic obstructive pulmonary disease (COPD), ...

OSA and COPD present with symptoms that often go undetected for too long. How can clinicians recognize symptoms faster?

The disappointing result means that AZ will be unable to follow in the footsteps of GSK, whose IL-5 inhibitor Nucala ...

Chronic respiratory diseases are among the top causes of death and disability worldwide, yet receive little political or ...

Professor of Respiratory Medicine and Allergy at the National Heart and Lung Institute, Imperial College London -- presented positive findings demonstrating the beneficial effects of Altesa ...

The effect of chronic breathlessness on the lives of patients and their loved ones is tremendous, regardless of the ...

An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...

A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.

Among patients with COPD, at least 50% reported that the disease impacts their daily life and emotional health, according to ...